iTeos Therapeutics (NASDAQ:ITOS – Get Rating) and Fennec Pharmaceuticals (NASDAQ:FENC – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability and risk. Volatility and Risk iTeos Therapeutics has a beta of […]
Fennec Pharmaceuticals (NASDAQ:FENC – Get Rating) and iTeos Therapeutics (NASDAQ:ITOS – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, earnings, institutional ownership, risk and valuation. Risk & Volatility Fennec Pharmaceuticals has a beta of […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
DekaBank Deutsche Girozentrale lifted its stake in shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS – Get Rating) by 9.7% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 11,300 shares of the company’s stock after acquiring an additional 1,000 shares during the quarter. […]
iTeos Therapeutics, Inc. (NASDAQ:ITOS – Get Rating) Director David Hallal sold 1,171 shares of the business’s stock in a transaction on Thursday, June 9th. The stock was sold at an average price of $19.51, for a total transaction of $22,846.21. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which […]